BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1331 related articles for article (PubMed ID: 9309539)

  • 21. Hyperprolactinemia caused by lactation and pituitary adenomas is associated with altered serum calcium, phosphate, parathyroid hormone (PTH), and PTH-related peptide levels.
    Kovacs CS; Chik CL
    J Clin Endocrinol Metab; 1995 Oct; 80(10):3036-42. PubMed ID: 7559893
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunochemical characterization of circulating parathyroid hormone-related protein in patients with humoral hypercalcemia of cancer.
    Burtis WJ; Brady TG; Orloff JJ; Ersbak JB; Warrell RP; Olson BR; Wu TL; Mitnick ME; Broadus AE; Stewart AF
    N Engl J Med; 1990 Apr; 322(16):1106-12. PubMed ID: 2320080
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Levels of parathyroid hormone-related protein (PTHrP) in hypercalcemia of malignancy are not lowered by treatment with the bisphosphonate BM 21.0955.
    Blind E; Raue F; Meinel T; Wüster C; Ziegler R
    Horm Metab Res; 1993 Jan; 25(1):40-4. PubMed ID: 8428711
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Development of a sensitive two-site immunoradiometric assay for parathyroid hormone-related peptide: evidence for elevated levels in plasma from patients with adult T-cell leukemia/lymphoma and B-cell lymphoma.
    Ikeda K; Ohno H; Hane M; Yokoi H; Okada M; Honma T; Yamada A; Tatsumi Y; Tanaka T; Saitoh T
    J Clin Endocrinol Metab; 1994 Nov; 79(5):1322-7. PubMed ID: 7962324
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Parathyroid hormone-related protein and life expectancy in hypercalcemic cancer patients.
    Pecherstorfer M; Schilling T; Blind E; Zimmer-Roth I; Baumgartner G; Ziegler R; Raue F
    J Clin Endocrinol Metab; 1994 May; 78(5):1268-70. PubMed ID: 8175989
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Diagnostic significance of parathyroid hormone-related protein in tumor patients with hypercalcemia].
    Blind E; Raue F; Meinel T; Pecherstorfer M; Räth U; Schmidt-Gayk H; Kohl B; Ziegler R
    Dtsch Med Wochenschr; 1993 Mar; 118(10):330-5. PubMed ID: 8453901
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Circulating parathyroid hormone-related protein (109-141) in malignancy-associated hypercalcemia.
    Nagasaki K; Otsubo K; Kajimura N; Tanaka R; Watanabe H; Tachimori Y; Kato H; Yamaguchi H; Saito D; Watanabe T; Adachi I; Yamaguchi K
    Jpn J Clin Oncol; 1996 Feb; 26(1):6-11. PubMed ID: 8551669
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Measurement of circulating parathyroid hormone-related protein in rats with humoral hypercalcemia of malignancy using a two-site immunoradiometric assay.
    Gaich G; Burtis WJ
    Endocrinology; 1990 Sep; 127(3):1444-9. PubMed ID: 2387260
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Parathyroid hormone-related protein-(1--36) stimulates renal tubular calcium reabsorption in normal human volunteers: implications for the pathogenesis of humoral hypercalcemia of malignancy.
    Syed MA; Horwitz MJ; Tedesco MB; Garcia-Ocaña A; Wisniewski SR; Stewart AF
    J Clin Endocrinol Metab; 2001 Apr; 86(4):1525-31. PubMed ID: 11297578
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunoassays for parathyroid hormone 1-84 in the diagnosis of hyperparathyroidism.
    Nussbaum SR; Potts JT
    J Bone Miner Res; 1991 Oct; 6 Suppl 2():S43-50; discussion S61. PubMed ID: 1722383
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Raised plasma concentrations of parathyroid hormone related peptide in hypercalcemic multiple myeloma.
    Horiuchi T; Miyachi T; Arai T; Nakamura T; Mori M; Ito H
    Horm Metab Res; 1997 Sep; 29(9):469-71. PubMed ID: 9370119
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Parathyroid hormone-related peptide in plasma of patients with hypercalcemia and malignant lesions.
    Kao PC; Klee GG; Taylor RL; Heath H
    Mayo Clin Proc; 1990 Nov; 65(11):1399-407. PubMed ID: 1700240
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Determination of intact parathyroid hormone in patients with calcium metabolism disorders].
    Birkeland KI; Falch JA; Gautvik KM; Gjestvang FT; Holst N; Haug E
    Tidsskr Nor Laegeforen; 1991 Jun; 111(15):1840-4. PubMed ID: 1853314
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Survival in hypercalcaemic patients with cancer and co-existing primary hyperparathyroidism.
    Hutchesson AC; Bundred NJ; Ratcliffe WA
    Postgrad Med J; 1995 Jan; 71(831):28-31. PubMed ID: 7708588
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serum parathyroid hormone-related protein levels and response to bisphosphonate treatment in hypercalcemia of malignancy.
    Rizzoli R; Thiébaud D; Bundred N; Pecherstorfer M; Herrmann Z; Huss HJ; Rückert F; Manegold C; Tubiana-Hulin M; Steinhauer EU; Degardin M; Thürlimann B; Clemens MR; Eghbali H; Body JJ
    J Clin Endocrinol Metab; 1999 Oct; 84(10):3545-50. PubMed ID: 10522993
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Increased prevalence of primary hyperparathyroidism in treated breast cancer.
    Fierabracci P; Pinchera A; Miccoli P; Conte PF; Vignali E; Zaccagnini M; Marcocci C; Giani C
    J Endocrinol Invest; 2001 May; 24(5):315-20. PubMed ID: 11407650
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Circulating PTH and PTHrP levels before and after treatment of tumor induced hypercalcemia with Pamidronate Disodium (APD).
    Grill V; Murray RM; Ho PW; Santamaria JD; Pitt P; Potts C; Jerums G; Martin TJ
    J Clin Endocrinol Metab; 1992 Jun; 74(6):1468-70. PubMed ID: 1592895
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lung cancer associated with hypercalcemia induced by concurrently elevated parathyroid hormone and parathyroid hormone-related protein levels.
    Uchimura K; Mokuno T; Nagasaka A; Hayakawa N; Kato T; Yamazaki N; Kobayashi T; Nagata M; Kotake M; Itoh M; Tsujimura T; Iwase K
    Metabolism; 2002 Jul; 51(7):871-5. PubMed ID: 12077733
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Conventional and new diagnostic applications of a two-site immunochemiluminometric assay for parathyroid hormone.
    Minisola S; Scarnecchia L; Romagnoli E; Carnevale V; Pacitti MT; Scarda A; Rosso R; Mazzuoli GF
    J Endocrinol Invest; 1992; 15(7):483-9. PubMed ID: 1447486
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Malignancy-associated hypercalcaemia: resolution of controversies over vitamin D metabolism by a pathophysiological approach to the syndrome.
    Schweitzer DH; Hamdy NA; Frölich M; Zwinderman AH; Papapoulos SE
    Clin Endocrinol (Oxf); 1994 Aug; 41(2):251-6. PubMed ID: 7923831
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 67.